DANIELLE BIBELHAUSER: Open Payments
NPI 1275075913 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 22 payments from 10 companies in 2025. Trend: 2023 $351 · 2024 $625 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $131 |
| Exeltis, USA Inc. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $39 |
| Astellas Pharma US Inc | 2 | $38 |
| Amgen Inc. | 2 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Organon LLC | 1 | $8 |
Products named: ZURZUVAE, SLYND, GEMTESA, Veozah, EVENITY, MONOFERRIC, APTIMA, Exparel.
Industry payments across IN — which companies pay providers there.
